El dilema de la reducción de tratamiento en pacientes con asma moderado-grave controlados

Marín Romero, S; Jara Palomares, L.
Rev. clín. esp. (Ed. impr.) ; 220(2): 117-118, mar. 2020.
Artículo en Español | IBECS (España) | ID: ibc-186422

Documentos relacionados

  1. Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
  2. Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
  3. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
  4. Treatment strategies for the yellow zone.
  5. The efficacy and safety of different long-acting ß2-agonists combined with inhaled glucocorticoid regimens in patients with asthma: a network meta-analysis.
  6. Existe-t-il un risque accru d'évènement cardiovasculaire immédiatement après une poussée de goutte ?
  7. Detecting symptom exaggeration and minimization using translated versions of the MMPI-2 and MMPI-2-RF: A systematic review and preliminary meta-analysis.
  8. Flare in Systemic Lupus Erythematosus: Lost in Translation?
  9. Investigating gout flares: beyond a definition.
  10. Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study.